| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/21/2023 | 48.64% | Truist Securities | $8 → $9 | Maintains | Buy |
| 11/20/2023 | 32.12% | Mizuho | $7 → $8 | Maintains | Buy |
| 11/16/2023 | -17.42% | Morgan Stanley | $4.5 → $5 | Maintains | Equal-Weight |
| 11/08/2023 | 48.64% | Susquehanna | → $9 | Initiates Coverage On | → Positive |
| 10/31/2023 | -0.91% | Wells Fargo | → $6 | Initiates Coverage On | → Equal-Weight |
| 10/20/2023 | 23.86% | UBS | → $7.5 | Assumes | Buy → Buy |
| 08/24/2023 | 15.61% | Mizuho | $6 → $7 | Maintains | Buy |
| 08/16/2023 | -33.94% | BTIG | → $4 | Downgrades | Neutral → Sell |
| 08/14/2023 | 15.61% | Barclays | $6 → $7 | Maintains | Overweight |
| 08/09/2023 | 32.12% | Berenberg | $5 → $8 | Upgrades | Hold → Buy |
| 07/21/2023 | 15.61% | Deutsche Bank | $7 → $7 | Reiterates | Buy → Buy |
| 06/23/2023 | 48.64% | Truist Securities | → $9 | Reiterates | Buy → Buy |
| 06/14/2023 | — | BTIG | Initiates Coverage On | → Neutral | |
| 06/13/2023 | -17.42% | Berenberg | → $5 | Initiates Coverage On | → Hold |
| 06/01/2023 | -17.42% | B of A Securities | → $5 | Initiates Coverage On | → Neutral |
| 05/16/2023 | -0.91% | Mizuho | $7 → $6 | Maintains | Buy |
| 05/11/2023 | 32.12% | Citigroup | $9 → $8 | Maintains | Buy |
| 05/10/2023 | -17.42% | Wells Fargo | $5.5 → $5 | Maintains | Underweight |
| 05/10/2023 | — | Credit Suisse | Maintains | Outperform | |
| 04/11/2023 | -17.42% | Keefe, Bruyette & Woods | $6 → $5 | Maintains | Market Perform |
| 04/06/2023 | 15.61% | Deutsche Bank | → $7 | Initiates Coverage On | → Buy |
| 04/05/2023 | -17.42% | Keybanc | $6 → $5 | Maintains | Overweight |
| 04/03/2023 | -25.68% | Morgan Stanley | $8 → $4.5 | Maintains | Overweight |
| 03/29/2023 | 15.61% | Mizuho | $8 → $7 | Maintains | Buy |
| 03/27/2023 | -9.17% | Wolfe Research | → $5.5 | Upgrades | Peer Perform → Outperform |
| 03/02/2023 | 48.64% | Citigroup | $13 → $9 | Maintains | Buy |
| 03/02/2023 | -0.91% | Barclays | $10 → $6 | Maintains | Overweight |
| 03/01/2023 | -17.42% | DA Davidson | $7.25 → $5 | Maintains | Neutral |
| 03/01/2023 | 32.12% | Credit Suisse | $13.5 → $8 | Maintains | Outperform |
| 03/01/2023 | -0.91% | Goldman Sachs | $7 → $6 | Maintains | Neutral |
| 03/01/2023 | -0.91% | JP Morgan | $9 → $6 | Downgrades | Overweight → Neutral |
| 03/01/2023 | -0.91% | Keybanc | $9 → $6 | Maintains | Overweight |
| 02/28/2023 | 32.12% | Morgan Stanley | $14 → $8 | Maintains | Overweight |
| 01/09/2023 | 7.35% | Wells Fargo | $7 → $6.5 | Maintains | Underweight |
| 01/09/2023 | 48.64% | Keybanc | $10 → $9 | Maintains | Overweight |
| 12/12/2022 | 32.12% | Mizuho | $10 → $8 | Maintains | Buy |
| 11/14/2022 | 65.15% | Barclays | $13 → $10 | Maintains | Overweight |
| 11/10/2022 | 15.61% | Goldman Sachs | $8 → $7 | Maintains | Neutral |
| 11/10/2022 | 65.15% | Keybanc | $12 → $10 | Maintains | Overweight |
| 11/09/2022 | 19.74% | DA Davidson | → $7.25 | Initiates Coverage On | → Neutral |
| 11/07/2022 | 131.21% | Morgan Stanley | $15 → $14 | Maintains | Overweight |
| 10/13/2022 | 98.18% | Truist Securities | $16 → $12 | Maintains | Buy |
| 09/22/2022 | 32.12% | Wedbush | → $8 | Initiates Coverage On | → Neutral |
| 09/08/2022 | 15.61% | Wells Fargo | $11 → $7 | Downgrades | Equal-Weight → Underweight |
| 08/15/2022 | 65.15% | Mizuho | $12 → $10 | Maintains | Buy |
| 08/15/2022 | 114.7% | Barclays | $19 → $13 | Maintains | Overweight |
| 08/11/2022 | — | Wells Fargo | Downgrades | Overweight → Equal-Weight | |
| 08/11/2022 | 98.18% | Keybanc | $11 → $12 | Maintains | Overweight |
| 08/01/2022 | 81.67% | Keybanc | $10 → $11 | Maintains | Overweight |
| 06/07/2022 | 131.21% | UBS | → $14 | Initiates Coverage On | → Buy |
| 05/24/2022 | 147.73% | Morgan Stanley | → $15 | Upgrades | Equal-Weight → Overweight |
| 05/17/2022 | 98.18% | Mizuho | $17 → $12 | Maintains | Buy |
| 05/12/2022 | 114.7% | Wells Fargo | $15 → $13 | Maintains | Overweight |
| 05/12/2022 | 65.15% | Keybanc | $15 → $10 | Maintains | Overweight |
| 05/10/2022 | 147.73% | Keybanc | $20 → $15 | Maintains | Overweight |
| 05/04/2022 | 122.96% | Credit Suisse | → $13.5 | Initiates Coverage On | → Outperform |
| 04/14/2022 | 114.7% | Piper Sandler | → $13 | Initiates Coverage On | → Overweight |
| 04/06/2022 | 213.79% | Barclays | $17 → $19 | Maintains | Overweight |
| 04/05/2022 | 147.73% | Wells Fargo | → $15 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 147.73% | Morgan Stanley | → $15 | Initiates Coverage On | → Equal-Weight |
| 03/15/2022 | 180.76% | Barclays | $20 → $17 | Maintains | Overweight |
| 03/10/2022 | 263.34% | JP Morgan | $33 → $22 | Maintains | Overweight |
| 03/10/2022 | 230.31% | Truist Securities | $30 → $20 | Maintains | Buy |
| 03/10/2022 | 114.7% | Keefe, Bruyette & Woods | $17 → $13 | Maintains | Market Perform |
| 03/10/2022 | 230.31% | Keybanc | $25 → $20 | Maintains | Overweight |
| 01/26/2022 | 246.82% | Citigroup | $36 → $21 | Maintains | Buy |
| 01/18/2022 | 197.27% | Goldman Sachs | → $18 | Initiates Coverage On | → Neutral |
| 01/14/2022 | 312.88% | Keybanc | $38 → $25 | Maintains | Overweight |
| 01/13/2022 | 230.31% | Mizuho | $27 → $20 | Upgrades | Neutral → Buy |
| 01/06/2022 | 180.76% | Keefe, Bruyette & Woods | → $17 | Initiates Coverage On | → Market Perform |
| 12/21/2021 | 213.79% | Loop Capital | → $19 | Initiates Coverage On | → Hold |
| 11/03/2021 | 329.4% | SMBC Nikko | → $26 | Initiates Coverage On | → Underperform |
| 11/02/2021 | 527.58% | Keybanc | $35 → $38 | Maintains | Overweight |
| 08/18/2021 | 511.07% | Truist Securities | → $37 | Initiates Coverage On | → Buy |
| 07/06/2021 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 07/06/2021 | 494.55% | Citigroup | → $36 | Initiates Coverage On | → Buy |
| 07/06/2021 | 478.03% | Barclays | → $35 | Initiates Coverage On | → Overweight |
| 07/06/2021 | 445% | JP Morgan | → $33 | Initiates Coverage On | → Overweight |
| 07/06/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/06/2021 | 478.03% | Keybanc | → $35 | Initiates Coverage On | → Overweight |
| 06/25/2021 | 312.88% | Mizuho | → $25 | Initiates Coverage On | → Neutral |
What is the target price for Marqeta (MQ)?
The latest price target for Marqeta (NASDAQ: MQ) was reported by Truist Securities on November 21, 2023. The analyst firm set a price target for $9.00 expecting MQ to rise to within 12 months (a possible 48.64% upside). 36 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Marqeta (MQ)?
The latest analyst rating for Marqeta (NASDAQ: MQ) was provided by Truist Securities, and Marqeta maintained their buy rating.
When is the next analyst rating going to be posted or updated for Marqeta (MQ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Marqeta, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Marqeta was filed on November 21, 2023 so you should expect the next rating to be made available sometime around November 21, 2024.
Is the Analyst Rating Marqeta (MQ) correct?
While ratings are subjective and will change, the latest Marqeta (MQ) rating was a maintained with a price target of $8.00 to $9.00. The current price Marqeta (MQ) is trading at is $6.06, which is out of the analyst's predicted range.